PM · 10-Q · 2026Q3 · Full report
ZYN Ultra FDA Authorization
Philip Morris International Inc. · 2026-10-23 · Importance 47 · Surprise 60
On August 21, 2026, the FDA authorized marketing of 11 ZYN ULTRA nicotine pouch products, including all 9 mg variants and one 11 mg variant. The FDA found that the new products, including the authorized 11 mg variant, contain lower levels of most harmful and potentially harmful constituents than other oral and smokeless tobacco products. Additional 11 mg variants remain under scientific review.